FDA Inspection 1063146 — Adare Pharmaceuticals, Inc.
The FDA completed an inspection of Adare Pharmaceuticals, Inc. on Jul 11, 2018 in Vandalia, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vandalia, OH (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)